Skip to Content
Merck
  • PAI-1 protein is a key molecular effector in the transition from normal to PTSD-like fear memory.

PAI-1 protein is a key molecular effector in the transition from normal to PTSD-like fear memory.

Molecular psychiatry (2021-01-30)
C Bouarab, V Roullot-Lacarrière, M Vallée, A Le Roux, C Guette, M Mennesson, A Marighetto, A Desmedt, P V Piazza, J M Revest
ABSTRACT

Moderate stress increases memory and facilitates adaptation. In contrast, intense stress can induce pathological memories as observed in post-traumatic stress disorders (PTSD). A shift in the balance between the expression of tPA and PAI-1 proteins is responsible for this transition. In conditions of moderate stress, glucocorticoid hormones increase the expression of the tPA protein in the hippocampal brain region which by triggering the Erk1/2MAPK signaling cascade strengthens memory. When stress is particularly intense, very high levels of glucocorticoid hormones then increase the production of PAI-1 protein, which by blocking the activity of tPA induces PTSD-like memories. PAI-1 levels after trauma could be a predictive biomarker of the subsequent appearance of PTSD and pharmacological inhibition of PAI-1 activity a new therapeutic approach to this debilitating condition.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Phosphatase Inhibitor Cocktail 3, DMSO solution
Sigma-Aldrich
Protease Inhibitor Cocktail, for use with mammalian cell and tissue extracts, DMSO solution
Sigma-Aldrich
Corticosterone: HBC complex, free flowing powder
Sigma-Aldrich
Plasminogen Activator Inhibitor-1, Mutant, Human, Recombinant, The Plasminogen Activator Inhibitor-1, Mutant, Human, Recombinant controls the biological activity of Plasminogen Activator. This small molecule/inhibitor is primarily used for Protease Inhibitors applications.
Supelco
4-Chloromethcathinone (4-CMC HCl) hydrochloride solution, 1 mg/mL in methanol (as free base), certified reference material, ampule of 1 mL, Cerilliant®